Indeed, studies have shown that the combined monitoring of serum levels of CA125 and HE4 is likely to significantly improve the sensitivity for detection of ovarian cancer in women with pelvic mass [67]. This evidence concerns the gene WFDC2 and ovarian carcinoma.